ReviewObesity pillars2026
Obesity and female reproductive health in Asian population.
Review in Obesity pillars, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity is a rising global health issue, especially among women, with important effects on reproductive health. This problem is becoming more urgent in Asia, reflecting worldwide trends in increasing rates. Despite expanding evidence, integrated guidance remains limited. This narrative clinical review synthesizes current evidence to provide practical clinical recommendations. Methods: This was a narrative clinical review informed by expert opinion and developed by the Thai Interest Group in Obesity and Female Reproductive Health through an interdisciplinary collaborative process. The approach included a comprehensive literature review across various databases to gather high-quality scientific evidence, clinical guidelines, and epidemiological data on the connection between obesity and female reproductive health. Results: The review summarizes current evidence on how obesity affects key reproductive conditions, including polycystic ovary syndrome (PCOS), infertility, and menopause. Obesity is strongly associated with PCOS, contributing to hormonal imbalances, insulin resistance, and metabolic dysfunction. It also impacts fertility by disrupting ovarian function and increasing the risk of pregnancy complications. Furthermore, menopausal women with obesity face higher risks of cardiovascular disease, metabolic disorders, and severe menopausal symptoms due to increased visceral adiposity and hormonal changes. Evidence supports the role of weight management, including lifestyle changes and pharmacological interventions, in improving reproductive outcomes. Weight reduction has been shown to improve ovulation, menstrual regularity, and fertility in women with PCOS and obesity. Anti-obesity drugs have proven effective for weight loss and enhancing reproductive health. Conclusion: Obesity has significant negative effects on female reproductive health from adolescence to menopause but these issues can be reversed with effective weight management. With the increasing rate of obesity in Asia, healthcare professionals must prioritize weight management strategies to mitigate its harmful impact on women's reproductive health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.